CEL-SCI CorpAdd to My Watchlist

CVM:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 0.12
  • 0.02  21.18%
    Today's Change
  • 0.10
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 4/28/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding216 million
Market Cap$26 million
Return on Equity ttm-257.92%
Last DividendCVM:US does not pay a dividend
EPS: Year Actual ttm-0.111
EPS: Year Est. 9/17 ttm--
EPS: Quarterly Actual -- 0.01
EPS: Quarterly Est. -- --
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate78.57
Company Description
CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer.
Net Income$-11 million
Total Assets$12 million
Web Sitewww.cel-sci.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!